Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Abstract Background Parkinson’s disease (PD) is a systemic disease clinically defined by the degeneration of dopaminergic neurons in the brain. While alterations in the gut microbiome composition have been reported in PD, their functional consequences remain unclear. Herein, we addressed this questi...
Main Authors: | Federico Baldini, Johannes Hertel, Estelle Sandt, Cyrille C. Thinnes, Lorieza Neuberger-Castillo, Lukas Pavelka, Fay Betsou, Rejko Krüger, Ines Thiele, on behalf of the NCER-PD Consortium |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Biology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12915-020-00775-7 |
Similar Items
-
Genetic landscape of Parkinson’s disease and related diseases in Luxembourg
by: Zied Landoulsi, et al.
Published: (2023-12-01) -
Thioredoxin-2 Regulates SqrR-Mediated Polysulfide-Responsive Transcription via Reduction of a Polysulfide Link in SqrR
by: Takayuki Shimizu, et al.
Published: (2023-03-01) -
Mutant Huntingtin Derails Cysteine Metabolism in Huntington’s Disease at Both Transcriptional and Post-Translational Levels
by: Bindu D. Paul, et al.
Published: (2022-07-01) -
Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease
by: Velma T. E. Aho, et al.
Published: (2024-04-01) -
An Open-Label Case Series of Glutathione Use for Symptomatic Management in Children with Autism Spectrum Disorder
by: Karam Radwan, et al.
Published: (2023-11-01)